Kulmbach, Germany

Wilma Thuer


 

Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Munich, DE (2014)
  • Kulmbach, DE (2013 - 2019)

Company Filing History:


Years Active: 2013-2019

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: Innovations by Wilma Thuer: Pioneering Patents in RNA Delivery

Introduction: Wilma Thuer is an accomplished inventor based in Kulmbach, Germany, known for her contributions to the field of RNA delivery systems. With a portfolio of four patents, she has established a notable presence in biomedicine and biotechnology, focusing on innovative ways to enhance the delivery of RNA-interference therapies.

Latest Patents: Among her latest inventions, Thuer has developed compositions for the targeted delivery of siRNA (small interfering RNA) polynucleotides to hepatocytes in vivo. These compositions utilize co-targeted delivery polymers that facilitate the efficient penetration of cell membranes, allowing the RNAi polynucleotides to move from outside to inside the cell. The reversible modification of these polymers provides physiological responsiveness, making her innovations highly relevant for therapeutic applications.

Career Highlights: Throughout her career, Wilma Thuer has worked with prominent companies such as Roche Diagnostics Operations, Inc. and Arrowhead Madison, Inc. Her experience in these industry-leading organizations has allowed her to refine her expertise and contribute significantly to advancing RNA delivery technologies.

Collaborations: Thuer has collaborated with esteemed colleagues, including David B. Rozema and David L. Lewis. These collaborations have fostered an environment of shared knowledge and innovation, further enhancing the development of her groundbreaking inventions.

Conclusion: Wilma Thuer's contributions to RNA delivery systems cement her status as a leading inventor in the field. Her innovative patents not only push the boundaries of biomedicine but also hold promise for the future of targeted therapies. With her ongoing efforts, she continues to inspire the next generation of inventors and researchers in the biotechnology sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…